ArticleJournal of hematology & oncology2013

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

Federico Pozzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.